Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating temsirolimus in patients with metastatic neuroendocrine tumors has completed, with results posted in 2016, including cohorts…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Carcinoid Tumor
• Pancreatic Neuroendocrine Tumor
• Pulmonary Carcinoid Tumor

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Gastrointestinal Carcinoid Tumor, Pulmonary Carcinoid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2016-12-12